A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1
about
Crystal Structure of the Engineered Neutralizing Antibody M18 Complexed to Domain 4 of the Anthrax Protective AntigenIsolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infectionImmunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigenCD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax.Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFNγ.A requirement for FcγR in antibody-mediated bacterial toxin neutralization.Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins.Identification of peptide sequences as a measure of Anthrax vaccine stability during storage.Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.Antibodies against anthrax: mechanisms of action and clinical applications.Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxinAnalysis of epitope information related to Bacillus anthracis and Clostridium botulinum.Immunization of Mice with Anthrax Protective Antigen Limits Cardiotoxicity but Not Hepatotoxicity Following Lethal Toxin ChallengeMonoclonal antibodies and toxins--a perspective on function and isotype.Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant.MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen.Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvantStochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralizationDisease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodiesCombinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.In vitro evaluation, biodistribution and scintigraphic imaging in mice of radiolabeled anthrax toxinsGalactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage.Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies.Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax.Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage.Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens.Human serum contains a protease that protects against cytotoxic activity of Bacillus anthracis lethal toxin in vitro.Serum-Mediated Cleavage of Bacillus anthracis Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase.
P2860
Q27654632-4C7BC929-162E-4672-8F80-31E36FFCCA3BQ28389813-68C43AB1-9EFD-4108-AC7C-9A0645CCE8DFQ33334776-3F5C1216-6775-4F5D-81B2-59DE77675578Q33496407-3FF4B087-42BC-42C4-9A0C-29A0F0E6BBD3Q33769076-9A8941C3-F70F-4431-AC7C-F123F5D5447FQ33877222-2824B3E0-C5D5-43EE-92FB-BAD0728BF6F2Q33936452-F74F123A-8622-4BCD-9714-4A8E01AE8963Q34000070-C0D6F0AC-6405-4A00-8F05-C6590EE49C67Q34243378-3F7D0284-779F-49FB-9AD7-62E18CD32BE5Q34279040-8189112D-815D-45D3-A4F2-C06F3A988CEBQ34290957-1148BC3F-F1D8-4DF0-96EC-20BEB2F34636Q35459294-676F7E14-8E81-4030-BB83-9E777F4DA1B0Q35610439-3196E7B3-706C-4310-BE9E-005210B9677EQ35783925-454299CD-550F-4A28-8ACE-ED550668D9C2Q35869311-F710F976-3069-4A3D-A599-84DCDB5D7FBFQ35894690-99AC593A-1DDA-494A-8C19-43682BB3F5C1Q36099489-3A41AEB3-59CB-477A-A363-7412BF88D449Q36183762-1C89509D-8CFF-45A6-AEA4-1F3901371B3DQ36482706-958752D2-42C0-479A-9A62-0FD77EF9DF69Q36593900-3EEBC333-394B-4124-A79D-5FCB2B961764Q36733960-F3F36FAE-85F3-4ED8-BEC0-7754B0166E18Q36786293-77542FE6-F75E-4C6E-9EAB-6265D2B81BCFQ36911369-A0E88954-2AFB-4949-80CE-B9EF617B1E31Q37037248-69870DEE-681E-4FF5-B95E-2CD9D43ECB77Q37332530-B80EE668-3B3D-4A71-B97F-D991A32638ADQ37375729-3F6A419F-43E3-4E81-9F37-FFC8DD35393FQ37404847-7D923354-8B49-4867-AFA8-BD9CB24D9D3FQ37409957-23574B66-0829-41F8-96B7-671A774D931AQ37622662-C36DB603-457A-4322-9061-72587ECA5E6AQ37978622-AFF2051B-709B-4E24-9BA7-E28AF8B02EAEQ39755368-15DDAE90-FA08-474F-B3E4-65153622FC1DQ55379780-7A3E209E-0A49-4B33-9564-701E45F0A29B
P2860
A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@ast
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@en
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@nl
type
label
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@ast
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@en
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@nl
prefLabel
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@ast
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@en
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@nl
P2093
P2860
P356
P1476
A monoclonal antibody to Bacil ...... utralizing epitope in domain 1
@en
P2093
Antonio Nakouzi
David Goldman
Ekaterina Dadachova
Ekaterina Revskaya
Johanna Rivera
Nareen Abboud
P2860
P304
P356
10.1128/IAI.00150-06
P407
P577
2006-07-01T00:00:00Z